What is the appropriate oseltamivir (Tamiflu) dose for a 29‑lb (≈13 kg) child using the 6 mg/mL oral suspension?

Oseltamivir Dosing for a 29‑lb (13.2 kg) Child

For a 29‑lb (≈13 kg) child, administer 30 mg (5 mL of the 6 mg/mL oral suspension) twice daily for 5 days for treatment, or 30 mg (5 mL) once daily for 10 days for prophylaxis. 1, 2, 3

Weight‑Based Dosing Category

• A child weighing 29 lb (13.2 kg) falls into the ≤15 kg weight bracket, which determines all dosing recommendations for children ≥12 months of age. 1, 2, 3
• This weight‑based categorical system applies only to children ≥12 months; do not use it for infants under 1 year. 1, 4

Treatment Regimen (Acute Influenza)

• Dose & schedule: 30 mg orally twice daily for 5 days. 1, 2, 3
• Volume: Each 30 mg dose equals 5 mL of the 6 mg/mL oral suspension. 1, 4, 3
• Timing: Initiate treatment within 48 hours of symptom onset for maximum benefit—earlier initiation (within 12–24 hours) yields the greatest reduction in illness duration. 1, 2, 5
• Clinical benefit: Treatment shortens illness by approximately 1–1.5 days (24–36 hours) and reduces the risk of acute otitis media by 34%. 2, 5

Prophylaxis Regimen (Post‑Exposure)

• Dose & schedule: 30 mg orally once daily for 10 days after close contact with an infected individual. 1, 2, 3
• Volume: 5 mL of the 6 mg/mL oral suspension once daily. 1, 4, 3
• Timing: Begin prophylaxis within 48 hours of exposure for optimal effectiveness. 1, 2

Formulation & Administration

• Preferred formulation: Use the commercially manufactured 6 mg/mL oral suspension; if unavailable, a pharmacy may compound it from capsules according to package‑insert instructions. 1, 2, 3
• Measuring device: Use a calibrated oral dosing syringe or cup that accurately measures 5 mL—do not use household spoons. 1, 4
• Food effect: Administer with food to significantly reduce nausea and vomiting (the most common adverse effects, occurring in ~10–15% of patients); taking with meals does not impair antiviral efficacy. 2, 4, 5

Critical Dosing Pitfalls to Avoid

• Do not round up: A child weighing 13 kg should receive 30 mg, not 45 mg (which is reserved for children >15 kg to ≤23 kg). 1, 2
• Do not use infant dosing: The mg/kg dosing regimen (3 mg/kg or 3.5 mg/kg) applies only to infants <12 months; children ≥12 months use the weight‑based categorical system. 1, 2, 6
• Do not stop early: Complete the full 5‑day treatment course even if symptoms resolve earlier, to ensure adequate viral suppression and prevent resistance. 2, 4
• Do not use prophylaxis dosing for treatment: Once‑daily dosing is insufficient for treating symptomatic influenza; switch immediately to twice‑daily dosing if symptoms develop during prophylaxis. 2, 4

Renal Function Considerations

• Normal renal function: No dose adjustment is required. 1, 4, 3
• Creatinine clearance 10–30 mL/min: Reduce treatment dose to 30 mg once daily (instead of twice daily) for 5 days; prophylaxis becomes 30 mg once daily or every other day for 10 days. 1, 4, 3

Safety & Tolerability

• Common adverse effects: Nausea (10%) and vomiting (9%) are mild, transient, and markedly reduced when taken with food; only ~1% of patients discontinue therapy due to gastrointestinal effects. 2, 4, 5
• Neuropsychiatric concerns: Controlled trials and post‑marketing surveillance have not established a causal link between oseltamivir and neurologic or psychiatric events; treatment should not be withheld on this basis. 2, 4

High‑Risk Indications

• Children <2 years of age are at exceptionally high risk for influenza‑related complications, hospitalization, and death; treatment is strongly recommended regardless of vaccination status, illness severity, or time since symptom onset. 2, 4
• Treatment should also be considered when household contacts are <6 months old (who cannot be vaccinated) or have underlying medical conditions predisposing them to complications. 2, 4